… by US company Cosette Pharmaceuticals, Mayne Pharma Group Ltd (ASX … profitability. The Dermatology division delivered a mixed performance. Revenue … newer products in the second half of FY26. The … earnings recovery. Mayne Pharma shares were relatively muted …

… by supporting the private domestic pharmaceutical industry, and announced in … tending to over-prescribe so pharmacies profit. Mexico has one of the … ;/p> <h2 class="wp-block-heading … tending to over-prescribe so pharmacies profit.</p> …

… I clinical development in H2 2026 Simcere Zaiming … and a subsidiary of Simcere Pharmaceutical Group Limited (HKEX: … ; the impact of pharmaceutical industry regulation and healthcare … partners could generate lower revenues than expected. Such situations …

… transactions were announced in the second half of the year, after initial … recapitalization of OpenAI’s for-profit organization into a public … to share a portion of revenues from chip sales to China … the prevalence of CVRs in pharmaceutical and biotech M& …

FTSE 100 up 5 points at 9,779 BP replaces CEO after less than 2yrs Currys tops FTSE 350 risers after results  9.06am: Currys good H1 but only 10% of full year  Currys shares are up over 6% on some strong first-half results.  Analyst John Stevenson at Peel …

… about “sustainability” and “profitability.” As a result, our … we have established a revenue model through global technology … began generating operating profit in the second half of last year … partnering meetings with global pharmaceutical companies, with an eye …

MISSISSAUGA, Ontario, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its fiscal year and fourth quarter ended September 30, 2025 (“ …

… Revenue rose 1% year-over-year to $12.4 billion, but profit … Trangle Shares of Major Pharmaceutical Companies Rise After Agreeing … Reinstates Dividend, Issues Rosy Profit Outlook After 'Phenomenal … a solid foundation for second half success in Fiscal 2026, …

… reduce inefficiencies and increase profitability. Additionally, it provides … revenue momentum on a year-over-year basis in the fiscal second half … meaningful headwinds in the second half from our MD-eleven … really important to the pharma segment. That is sort …

… the financial front, Q2FY26, revenue was placed at ₹929.8 … management, it approaches the second half of 2025-26 with cautious … drop in revenues and net profits for Q2FY26. The revenues of the … vat dyes), agrochemicals and pharmaceutical APIs are all included in …